| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0023 | 1 |